Today, the screeners at HealthTechMovers.com picked up 4 HealthTech Stocks up over 80% past 10 days and have been added to our watchlist. These are very volatile stocks so please do your own research before you make any investments. While we list the ratings of various 3rd party services, we're not recommending these stocks and we're not paid by the featured tickers, we simply report the big movers. If the editor has a position, it will be noted below the charts.
MiningAndMetalMovers.com is also looking into these tickers AVY, CMC, MERC, LIN and more.
One resource you need to consider using Tipranks.com where as a premium member you get access to all buy ratings, price targets and insider trading signals. Click here for more on Tipranks.com.
Summary: Evofem Biosciences Inc. develops and anticipates commercializing products which support and promote women as the primary healthcare consumer. The company is identifying and developing new and novel products which specifically address unmet needs in the areas of sexual and reproductive health, the prevention of acquisition of sexually transmitted infections and products which address or promote general health and wellbeing. Evofem Biosciences Inc., formerly known as Neothetics Inc., is based in SAN DIEGO CA.
Recent EVFM Stock Price (approx 10:00am EST.): $1.19
Previous Close for EVFM Stock: $1.07
Percentage Price Change Past 10 Days for EVFM stock: +240%
TipRanks.com reports that Evofem Biosciences stock currently has 4 analysts offering 12-month price targets and the consensus is a Moderate Buy rating for EVFM stock with an average price target is $2.63.
Click here to get the full story on EVFM stock >>
Pricing & Percentages as of approximately 10:00am EST.
-----------------------------------------------------------------------------------------
Summary: MSP Recovery LLC. is a medicare, medicaid, commercial and secondary payer reimbursement recovery leader. It provides the healthcare industry with comprehensive compliance solutions. MSP Recovery LLC., formerly known as Lionheart Acquisition Corporation II, is based in CORAL GABLES, Fla.
Recent MSPR Stock Price (approx 10:00am EST.): $2.40
Previous Close for MSPR Stock: $2.19
Percentage Price Change Past 10 Days for MSPR stock: +153%
Click here to get the full story on MSPR stock >>
Pricing & Percentages as of approximately 10:00am EST.
-----------------------------------------------------------------------------------------
Summary: Clovis Oncology, Inc. is a biopharmaceutical companyfocused on acquiring, developing and commercializing innovative anti-cancer agents.'Clovis has only one marketed drug in its portfolio a poly ADP-ribose polymerase inhibitor, namely Rubraca that is approved for the treatment of certain patients with ovarian and prostate cancer.'Currently, Rubraca is approved in the United States for two indications specific to ovarian cancer in the second and third or later-line setting. The drug is also approved in the United States under accelerated approval as monotherapy for treating BRCA-mutant metastatic castrate-resistant prostate cancer.'A broad development program on Rubraca is currently underway across a variety of solid tumors. Clovis is looking to expand Rubraca's label into additional cancer types like breast and gastroesophageal cancers, among others. Meanwhile, Clovis holds global development and commercialization rights to Rubraca.
Recent CLVS Stock Price (approx 10:00am EST.): $1.78
Previous Close for CLVS Stock: $1.71
Percentage Price Change Past 10 Days for CLVS stock: +144%
Click here to get the full story on CLVS stock >>
Pricing & Percentages as of approximately 10:00am EST.
-----------------------------------------------------------------------------------------
Summary: Sera Prognostics Inc. is a women's health diagnostics company. It focused on improving maternal and neonatal health by providing pregnancy biomarker information to doctors and patients. Sera Prognostics Inc. is based in SALT LAKE CITY.
Recent SERA Stock Price (approx 10:00am EST.): $2.45
Previous Close for SERA Stock: $1.75
Percentage Price Change Past 10 Days for SERA stock: +80%
TipRanks.com reports that Sera Prognostics stock currently has 3 analysts offering 12-month price targets and the consensus is a Moderate Buy rating for SERA stock with an average price target is $8.50.
Click here to get the full story on SERA stock >>
Pricing & Percentages as of approximately 10:00am EST.
-----------------------------------------------------------------------------------------
Just a reminder, one resource you need to consider using Tipranks.com where as a premium member you get access to all buy ratings, price targets and insider trading signals. Click here for more on Tipranks.com.
The other great tool for charting is TradingView.com, so you might want to check that out too.
The information in this article was pulled from third part services. The prices listed above are not real-time and will be delayed at least 15 minutes.
MiningAndMetalMovers.com keeps investors informed of the top moving stocks within the mining and metal sector. We provide investors with timely information regarding top moving stocks in the health tech sector sourced from our proprietary stocks screens, partner stock analysts and breaking news that identify and monitor stocks that are on the move. Join thousands of investors who already signed up for our free subscription to MiningAndMetalMovers.com.